Tuesday, 22 October 2024
  
Login

Australia's most trusted
source of pharma news

Tuesday, 22 October 2024
Ascott 5
Ascott 5
Spot the difference: MSL or Rep?

A survey of Australian doctors has found that 60 per cent of GPs and 49 per cent of specialists cannot tell the difference between a pharma product rep and an MSL.

Which leaders are on the move?
New corporate affairs boss named and other appointments
TODAY
Orphan drug battle brews
Latest round of CHMP recommendations hints at upcoming filing
TODAY
Winter report card exposes vax gap
Despite high mortality, vax rates are low in 65+ age group
TODAY
Healthone
Healthone
Ex-J&J exec wins Aussie GM role
High-flyer takes next step in a flourishing career
21 October
PBAC delivers blow to major reform
September meeting outcomes dish up good... and bad news
21 October
AbbVie confirms ANZ job losses
Company confirms a 'reduction in roles' with focus on those impacted
18 October
Great workplace for the third time
More than an accolade: why this pharma is great to work for
18 October
ADG PRIME
ADG PRIME
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (15)

Access & Reimbursement (1)

Clinical & Medical, R&D (18)

Regulatory, Pharmacovigilance & QA (4)

Executive Roles (1)

Other (17)

Company finalises major rebrand
As it pivots its focus on a projected US$77B market
21 October
TGA debunks vax misinformation
Following incorrect reports on DNA contamination
21 October
Antiviral withdrawn from TGA
Pharma throws in the towel after trying for three years
21 October
TGA approves new Covid vax
Indicated for Aussies as young as six months
21 October Approvals Action
Aussie's next tilt at NASDAQ
Attracting US investors after making $2M-plus-a-day Q3
18 October
Jobs shake-up hits Aussie pharma
ICYMI: The stories that topped this week
18 October Your Week in Five Minutes
Novo adds sugar switch to insulin
Potential to improve risks and complications for diabetics
18 October
New standard could boost market
Identifying the many who don't know they have COPD
18 October
TGA delivers Biogen, Eisai a blow
Hyped drug rejected with upcoming 'closed meetings' confirmed
17 October
CEO wins commercialisation award
Recognised for significantly advancing the innovation ecosystem
17 October
Pharma execs start talent agency
High-flyers branch out on their own to recruit for industry
17 October
J&J celebrates new highest earner
It's the pharma's first drug to earn more than $4.5 billion in a quarter
17 October
Campaign targets hot topic
Encouraging more conversations about menopause
17 October
Competitive intelligence deal lands
Partnership to pinpoint the most promising therapies under trial
17 October
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.